期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2021; 22 (4)
Introduction Chronic spontaneous urticaria (CSU) refers to urticaria (wheals) or angioedema, which occur for a period of six weeks or longer without a......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2020; 21 (17)
Introduction Statins are the first-line treatment to reduce cardiovascular (CV) events, mainly by reducing low-density-lipoprotein cholesterol (LDL-C)......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2020; 21 (4)
Introduction: Chronic subdural hematoma (CSDH) is a common neurosurgical disease, whose incidence has been steadily increasing with our aging populati......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2020; 21 (7)
Introduction: Osteoarthritis (OA) is the leading cause of pain, loss of function and disability in the elderly, with the knee being the most impactful......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2020; 21 (11)
Introduction: Hypoglycemia in diabetes is a common and unresolved complication during diabetes therapy, even life-threatening. Effective and convenien......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2020; 21 (3)
Introduction: The prevalence of obesity is increasing worldwide and associated conditions, particularly type 2 diabetes mellitus (T2DM), also show inc......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2019; 20 (1)
Introduction: Statins are the first line of therapy to reduce low-density lipoprotein cholesterol (LDL-C) in order to decrease cardiovascular events. ......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2019; 20 (8)
Introduction: Cardiovascular disease is a major cause of morbidity and mortality throughout the world and hypercholesterolemia is one of the key risk ......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2019; 20 (14)
Introduction: A growth in the market for anti-diabetic drugs, along with an ever-increasing population suffering from type 2 diabetes mellitus (T2DM),......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2019; 20 (16)
Introduction: The abnormally activated JAK-STAT pathway plays a central role in the pathogenesis of BCR/ABL-negative myeloproliferative neoplasms (MPN......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2019; 20 (13)
Introduction: The increasing prevalence of comorbid depression and diabetes exerts a heavy burden on global health. Co-occurrence of depression and di......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2019; 20 (16)
Background: In this post hoc analysis in patients recently diagnosed (<= 5 years) with schizophrenia, the effect on hospitalization risk after swit......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2018; 19 (16)
Introduction: Sodium-dependent glucose transporter 2 (SGLT2) inhibitors are novel, potent oral anti-diabetic agents in a beta-cell function-independen......
期刊： EXPERT OPINION ON PHARMACOTHERAPY, 2018; 19 (8)
Introduction: Patients with advanced well-differentiated neuroendocrine tumors (NETs) who have bulky and/or symptomatic and/or rapidly progressive dis......
